Anticoagulation in atrial fibrillation-Reference-Cited by-同舟云学术

Anticoagulation in atrial fibrillation

Published:2020-10-28 Issue:5 Volume:107 Page:419-427
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Barra Sérgio^ORCID,Providência Rui

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference55 articles.

1. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation

2. Heart statistics . B HF Statistics Factsheet - UK. Available: file:///C:/Users/Sergio/Downloads/bhf-cvd-statistics-uk-factsheet.pdf [Accessed 1st March 2020].

3. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

4. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010

5. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rivaroxaban Versus Warfarin in the Treatment of Patients with Atrial Fibrillation and Previous Ischaemic Stroke/Tia - an Efficacy and Safety Evaluation;2024

2. Real‐world evidence that among atrial fibrillation patients warfarin is associated with reduced nonelective admissions compared with those on DOACs;Clinical Cardiology;2023-09-08

3. Current Stroke Clinical Outcomes of Direct Anticoagulation Therapy in Patients with Valvular Atrial Fibrillation: A Scoping Review;2023-02-26

4. Selección de lo mejor del año 2022 en cardiología geriátrica;REC: CardioClinics;2023-01

5. Pre- and postoperative left atrial appendage visualization: selecting the optimal method;Innovative Medicine of Kuban;2022-09-21